2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Pancreatic Neoplasms
16
Multiple Myeloma
13
Neoplasms
12
Colorectal Neoplasms
8
Neoplasms, Plasma Cell
7
Myelodysplastic Syndromes
7
Leukemia, Myeloid, Acute
6
Glioblastoma
5
Sarcoma
4
Prostatic Neoplasms
4
Leukemia, Myelomonocytic, Chronic
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Skin Neoplasms
3
Inflammation
3
Colonic Neoplasms
3
Stomatitis
2
Stomach Neoplasms
2
Recurrence
2
Primary Myelofibrosis
2
Ovarian Neoplasms
2
Neoplasms by Site
2
Myofibroma
2
Myeloproliferative Disorders
2
Lymphoma
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia
2
Glioma
2
Frailty
2
Interventions
AP 1903 reagent
3
ON 01910
2
Biopsy
2
thymoglobulin
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
decitabine and cedazuridine drug combination
1
cedazuridine
1
angiotensin I (1-7)
1
Vitamin B 12
1
Therapeutics
1
Specimen Handling
1
Sertraline
1
Pluvicto
1
Peripheral Blood Stem Cell Transplantation
1
Metformin
1
Interleukin-8
1
Immunotherapy, Adoptive
1
IDO-1 inhibitor LY3381916
1
HuMax-IL8
1
Granulocyte Colony-Stimulating Factor
1
Genetic Counseling
1
Folic Acid
1
Filgrastim
1
Exercise
1
Emapalumab
1
Decitabine
1
DNA
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cytopenia
×
Ascorbic Acid
×
Clear all
NCT03682029
2024-04-17
EVITA
Rigshospitalet, Denmark
Phase NA
Unknown
109 enrolled